Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > Washington Drug Letter > Bill Calls for Mandatory Reporting to Clinical Trials Registry

Washington Drug Letter

July 11, 2005 | Vol. 37 No. 27

Bill Calls for Mandatory Reporting to Clinical Trials Registry

Drug and device manufacturers would be required to submit clinical trial results to a federally managed database under legislation introduced by two prominent House Democrats.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives
Sample PDF

Related Articles

Senate Passes Stem Cell Bill Despite Presidential Veto Threat GSK Warns of Label Tampering on HIV Medications CMS Proposes Revised Clinical Trial Policy Supreme Court Rejects Generic Lipitor Case

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.